A systematic review and aggregated analysis on the impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being evaluated for Alzheimer's Disease

Manuscript Number: 

17-1093R1

Author(s): 
Anastasia Chalkidou, Enrico R. Fantoni, Gill Farrar, Alexander Hammers, John T. O’Brien

Disclosures

Anastasia Chalkidou

  • Nothing to Disclose

Enrico R. Fantoni

  • Sponsors:
    I am employed by GE Healthcare

Gill Farrar

  • Sponsors:
    Medical Affairs Professional at GE Healthcare

Alexander Hammers

  • Equity:
    Very minor holding in Imperial Innovations
    Patents/Royalties
    I am the inventor of the Hammers_mith atlases. Maximum probability maps based on these atlases have been licenced to industry via Imperial Innovations.
    Grants
    • Agency: 
      Two Siemens-sponsored co-supervised PhD studentships
      Dates: 
      2014-2016; 2018-2022

John T. O’Brien

  • Consulting Fees:
    Consultancy (GE Healthcare, TauRx, Avid/Lilly, Axon).
    Lecture Fees:
    Speaker fees (GE Healthcare, Pirimal).
    Grants
    • Agency: 
      Avid/Lilly